We undertook a prospective randomised controlled trial involving 400 patients with a displaced intracapsular fracture of the hip to determine whether there was any difference in outcome between treatment with a cemented Thompson hemiarthroplasty and an uncemented Austin-Moore prosthesis. The surviving patients were followed up for between two and five years by a nurse blinded to the type of prosthesis used.
Displaced intracapsular fractures of the neck of the femur are commonly treated by hemiarthroplasty. Orthopaedic surgeons are divided as to the relative merits of cemented versus uncemented prostheses in these patients. Cementing the prosthesis provides more secure fixation and may result in less residual pain and better function. However, the insertion of cement complicates the operation and carries the risk of cardiovascular collapse when the cement is introduced into the femur. 1 So far, six small randomised controlled trials involving 549 patients have been summarised in a Cochrane Review on this subject. This reported that patients with cemented prostheses have less pain and a tendency to better mobility than those with uncemented prostheses. 1 The authors concluded that there was limited evidence that cementing a prosthesis in place may reduce post-operative pain and lead to better mobility. They highlighted the need for further well-conducted randomised controlled trials.
The two most common types of hemiarthroplasty used for the treatment of a displaced intracapsular fracture in the United Kingdom are the uncemented Austin-Moore prosthesis and the cemented Thompson hemiarthroplasty. 2 The continued use of a mixture of uncemented and cemented prostheses reflects uncertainty as to the relative advantages and disadvantages of using bone cement. We therefore undertook a large randomised controlled trial comparing an uncemented Austin-Moore prosthesis with a cemented Thompson hemiarthroplasty in patients with a displaced intracapsular fracture of the proximal femur, with a minimum follow-up of two years'.
Materials and Methods
All patients presenting to our institution with a displaced intracapsular fracture of the proximal femur were considered for inclusion in the study. Patients with senile dementia were included with the consent of their next of kin. The inclusion and exclusion criteria are listed in Table I . All patients with an undisplaced or minimally displaced intracapsular fracture were excluded from the study and treated by internal fixation, as were all patients aged less than 60 years with a displaced fracture and those aged between 60 and 75 years in whom there was no impairment of mobility (defined as the ability to walk out of the house unaided) immediately prior to the injury.
The study had ethical approval and the support of the hospital research and development committee. Patients were randomised by the opening of a sealed opaque numbered envelope, prepared by a person independent of the study, containing details of the procedure to be undertaken. After randomisation all patients had to stay in the group to which they had been allotted, regardless of any deviations from the treatment protocol, and all results were analysed on an intention-to-treat basis. All operations were performed or supervised by one orthopaedic surgeon (MIP) and all by a standard anterolateral approach with repair of the joint capsule. The Austin-Moore prosthesis used (Stryker/Howmedica Ltd, Newbury, United Kingdom) was generally of the standard size, but if the femur was slender, a narrow-stem implant was used. The Thompson hemiarthroplasty (Corin Ltd, Cirencester, United Kingdom) was inserted after the femur had been prepared by reaming and saline irrigation. A Hardinge cement restrictor was used and Palacos bone cement with gentamicin (Schering-Plough Ltd, Welwyn Garden City, United Kingdom) was inserted in a retrograde manner into the femur using a cement gun. All patients received peri-operative antibiotic prophylaxis and 14 days of low molecular weight heparin as thromboembolic prophylaxis. After surgery all patients were mobilised as soon as they were able, with no restrictions on hip movements or weight-bearing. They were discharged home as soon as their general condition allowed.
Patients were initially reviewed six weeks after discharge. Subsequent assessments were by telephone at three, six, nine and 12 months, and thereafter every year for up to five years. All assessments were undertaken by a nurse who was blinded to the treatment undertaken. For those patients who could not be contacted, enquiry was made via their next of kin or their registered medical practitioner. Finally, if the patient could not be contacted, enquiry was made to the Office of Population Census Service. All surviving patients had a mean follow-up of 3.7 years (2 to 5). Three patients were lost to follow-up, two after four years and one after three years.
On admission the patient's mental state was assessed using a ten-point mental test score and their physical state by the American Society of Anaesthesiologists (ASA) score. 3, 4 Residential status was defined as living in their own home (including warden-controlled accommodation), residential care (partial care within an institution) or nursing care (full nursing care or hospital in-patient). For the follow-up assessments, pain was assessed using a visual analogue scale of one to ten at the outpatient clinic visit, with least pain scoring one, and also using a scale of one to six in which one was no pain; two occasional and slight pain; three pain when starting walking but then getting better with occasional analgesia; four with no or little pain at rest, pain with activities, frequent mild analgesia; five constant but bearable pain, stronger analgesia used occasionally; and six constant pain with frequent strong analgesia. 5 The one to six assessment scale was used for telephone follow-up assessments. The patient's walking ability immediately prior to the fall was assessed using a mobility scale of 0 to nine, 6, 7 where nine represented full mobility indoors and outdoors without walking aids and 0 defined a bedbound patient (Table II) . At each follow-up assessment the time until 16 activities of daily living were regained was also assessed.
Before commencing the study a power calculation was undertaken using the primary outcome of degree of residual pain at one year. The calculation was based on reducing the number of patients with a pain score of ≥ 3 by 10%. Allowing for deaths and loss to follow-up, it was estimated that 200 patients were required in each group. Statistical analysis. Binary outcomes for the two groups were analysed using Fisher's exact test, and continuous outcomes with the Mann-Whitney U test. Survival outcomes Table II . Mobility assessment tool
1.
Could they get about the house? 2.
Was the patient able to get out of the house? 3.
Could they do their shopping?
For each of the three questions: Without any difficulty -score 3 On their own with an aid -score 2 Only with someone else's help -score 1 Not at all. Bed or chair bound -score 0
were calculated using the Kaplan-Meier method, and comparison between the groups was performed using the Kaplan-Meier log-rank test. 8 A p-value of < 0.05 was considered statistically significant.
Results
Patients were recruited over a five-year period. The reasons for 700 patients not being included in the study are shown in Figure 1 . Among the 400 randomised patients, 11 in the cemented group did not have treatment as defined in the study protocol. Five patients were considered to be unfit for a cemented hemiarthroplasty immediately prior to or during surgery, having previously been considered fit for both procedures. Four of these were treated by reduction and internal fixation, and one had an uncemented Austin-Moore hemiarthroplasty. Four patients were found to have a femur that was too narrow to accommodate a Thompson prosthesis. Three were treated with an uncemented narrow-stem Austin-Moore and one with a cemented bipolar hemiarthroplasty. One patient was found at the time of surgery to have a trochanteric fracture and not an intracapsular fracture, but was still treated with a cemented Thompson hemiarthroplasty, and one further patient was later found to have a pathological fracture from a secondary tumour. A further 11 patients in the uncemented group did not have treatment as defined in the study protocol. Seven were felt to have a prosthesis that was loose at the time of surgery, either because of a large femoral cavity or from an operative fracture of the femur, and the prosthesis was therefore cemented in place. Two patients, initially considered fit for hemiarthroplasty, were considered unfit at the time of surgery and treated by reduction and internal fixation. A further two patients were later found to have a pathological fracture secondary to a tumour. Patient characteristics. The characteristics of the two groups of patients are detailed in Table III . None of the differences between the two groups was statistically significant. Operative details. The operative details and total hospital stay for the two groups are shown in Table IV . The mean duration of surgery was approximately seven minutes longer for those who had a cemented prosthesis. There were no differences in requirements for blood transfusion related to the type of procedure. The total hospital stay was the time spent on the orthopaedic and any other wards, including medical and rehabilitation wards, until discharge from hospital. The readmissions included were only those for conditions directly related to the hip fracture. Total hospital stay was found to be four days shorter for those treated with a cemented prosthesis. In the uncemented group there were 14 intraoperative femoral fractures. Of these, six had the Austin-Moore cemented in place during the procedure, and one had a revision a few days later, when the implant was converted to a cemented prosthesis. For the remaining patients the fractures were considered not to require any change in treatment and were managed with the standard mobilisation regimen. In the cemented hemiarthroplasty group, two patients had cement retained in the acetabulum which was only seen on the post-operative radiograph. No further treatment was necessary for this. In addition to the details given in Table IV , one patient had a cardiac arrest on the operating table after insertion of the cement. The patient however made an uneventful recovery. General complications. The general medical complications are listed in Table V . There were no statistically significant Table VI . Three of the six patients who were considered unfit for hemiarthroplasty at the time of surgery and were therefore treated by reduction and internal fixation, developed nonunion and had the fixation revised to a hemiarthroplasty. The other revisions to hemiarthroplasty or total hip replacement were all for pain in the hip caused by either loosening of the prosthesis or acetabular wear. In total 21 further anaesthetics were required in 11 patients in the cemented group compared to 21 further anaesthetics in 18 patients in the uncemented group. Mortality. The mortality at one year for the cemented prosthesis was 25% and for the uncemented was 28% (Fig. 2) . At no time was there any statistically significant difference between the groups. Residual pain. The mean degree of residual pain for the patients assessed is shown in Table VII and Figure 3 . The group of patients treated by the cemented prosthesis had lower pain scores, signifying less pain, for all the assessments, although only the results on the visual analogue scale, at eight weeks and at three, six, 12 and 24 months by telephone assessment were statistically significant. Mobility. The differences between the admission mobility score and that at each of the post-operative follow-up assessments are shown in Table VIII . The scores were all lower for the cemented prosthesis, signifying that patients so treated regained a better degree of mobility. Activities of daily living. There was no statistically significant difference between the two groups for the 16 activities assessed, except for three in which function was regained more rapidly in those treated by cemented arthroplasty. These activities were the ability to bend down and pick up an object from the floor (mean 15. 
Discussion
This study is the largest randomised trial to date on this topic and confirms the results of the previous smaller studies of patients with an intracapsular hip fracture which found that a cemented hemiarthroplasty leads to less residual pain and a better return of mobility than an uncemented prosthesis. 1 We were able to demonstrate that the marginally increased operation time and the potential operative complications associated with cement were not detrimental. Indeed, the reverse was true, with a clear trend to fewer general medical complications, fewer re-operations and a shorter hospital stay with the cemented prosthesis.
The strengths of this study include the broad entry criteria, the large number of patients included, standardisation of treatment procedures, the lack of patients lost to follow-up, and the blinded assessment of outcome. The most important outcomes measured were mortality, pain and return of function. At the initial outpatient visit we assessed pain using both a visual analogue scale and a pain score as described by Charnley. 5 For this elderly population it was found that the Charnley pain score was the most appropriate method of assessment for follow-up by telephone. We are not aware of any studies that have specifically validated the Charnley pain score, but the questions used form the basis of most of the arthroplasty assessment scores which have been widely used and validated.
Many outcome measures were used in this study (approximately 50 comparisons). This may result in an α error, in which, when a p-value of < 0.05 is chosen as the level of statistical significance, one result in 20 may show such a p-value. Using a Bonferroni correction, a p-value of 0.05/50 (i.e., 0.001) may be used. If this is applied to the key outcome measure of residual pain, this still remains statistically significant. Hence, the key finding in this study of reduced residual pain for the cemented prosthesis is extremely unlikely to be due to statistical chance.
The outcome of secondary surgery, particularly revision of the implant, was not significantly different between the two groups, although there was a tendency to more revision arthroplasties in the uncemented group. The outcome of revision rate for this population is not so significant as that for elective hip arthroplasty, as the elderly population in this study are less likely to undergo a revision arthroplasty, even if significant symptoms of residual pain exist. Data from the Australian National Joint Replacement Registry 9 have demonstrated a reduced need for revision surgery for a cemented Thompson prosthesis compared with an uncemented Austin-Moore. For 15 000 registered cases, the rate of revision surgery was significantly higher (p < 0.001) for the uncemented prosthesis. The Australian database found that four years after surgery the rate of revision was approximately 4% for the Thompson versus 6% for the Austin-Moore prosthesis. This is comparable with the finding in this study of a rate of revision to total hip replacement of 3% for the cemented Thompson and 6% for the uncemented Austin-Moore.
Previously published randomised trials comparing cemented and uncemented hemiarthroplasties for patients with a fracture of the hip have been identified and summarised in the Cochrane Review on this subject.
1 Sonne-Holm, Walter and Jensen, 10 in 1982, compared the results of a cemented and an uncemented Austin-Moore hemiarthroplasty in 112 patients. There was no difference in mortality between the two groups. Better walking ability and less pain was observed in those treated with the cemented prosthesis. Similar findings were recorded in a later study of 50 patients which compared a cemented and an uncemented bipolar hemiarthroplasty. 11 There was no difference in mortality between the groups, but significantly less pain in those treated with the cemented Graph showing mean pain scores related to the type of treatment given.
prosthesis. Walking ability was also superior with the cemented prosthesis. Santini et al 12 also compared a cemented and an uncemented bipolar hemiarthroplasty in 106 patients. Again, there was no difference in mortality or functional activity between the two groups. Two studies involving a total of 190 patients compared a cemented with an uncemented Thompson prosthesis. Both reported no statistically significant difference between the groups for mortality, and significantly more residual pain in those treated with an uncemented prosthesis. 13, 14 Branfoot, Faraj and Porter 15 also compared a cemented with an uncemented Thompson prosthesis in 91 patients and reported no significant difference in mortality. The mean pain scores in the 70 surviving patients tended to be higher, indicating more pain, for the uncemented prosthesis, although the results were not statistically significant.
We chose the two prostheses used in this study as they are currently the most commonly used in the United Kingdom. It is possible that a modern uncemented prosthesis, perhaps with hydroxyapatite coating may produce superior outcomes to the uncemented Austin-Moore prosthesis which we used, but this remains to be proved in a randomised controlled trial. The only study that has compared an uncemented Austin-Moore with a hydroxyapatite-coated Furlong prosthesis in 84 patients was too small to make any definite conclusions on any difference between the two implants. 16 In summary, this study found that a cemented Thompson hemiarthroplasty led to less pain in the hip, improved return of mobility and a reduced hospital stay compared to an uncemented Austin-Moore prosthesis. There was no increase in complications or mortality related to the use of cement. In conjunction with previous studies which have also reported improved outcomes for a cemented rather than an uncemented hemiarthroplasty, we suggest that when a hemiarthroplasty is used for a fracture of the hip it should be cemented in place. 
